Favorable FDA Panel Reviews Propel Biomet, Cyberonics Stocks In June
This article was originally published in The Gray Sheet
Executive Summary
Biomet shares climbed 10.8% in June, spurred by completion of a $280 mil. Interpore Cross acquisition and investor confidence in future knee sales growth